Below are the most recent publications written about "Iloprost" by people in Profiles.
-
Pelletier GJ. Invited commentary. Ann Thorac Surg. 2012 Sep; 94(3):798-9.
-
Biscetti F, Gaetani E, Flex A, Straface G, Pecorini G, Angelini F, Stigliano E, Aprahamian T, Smith RC, Castellot JJ, Pola R. Peroxisome proliferator-activated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulation. J Vasc Res. 2009; 46(2):103-8.
-
Biscetti F, Pola R. Endothelial progenitor cells and angiogenesis join the PPARty. Circ Res. 2008 Jul 03; 103(1):7-9.
-
Wilson SJ, Dowling JK, Zhao L, Carnish E, Smyth EM. Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization. Arterioscler Thromb Vasc Biol. 2007 Feb; 27(2):290-6.
-
Wigley FM, Korn JH, Csuka ME, Medsger TA, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Arthritis Rheum. 1998 Apr; 41(4):670-7.
-
Boie Y, Rushmore TH, Darmon-Goodwin A, Grygorczyk R, Slipetz DM, Metters KM, Abramovitz M. Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem. 1994 Apr 22; 269(16):12173-8.
-
Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA, Steen VD, Varga J, Jimenez S, Mayes M, Clements PJ, Weiner SR, Porter J, Ellman M, Wise C, Kaufman LD, Williams J, Dole W. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med. 1994 Feb 01; 120(3):199-206.
-
Appasamy PM, Pendino K, Schmidt RR, Chepenik KP, Prystowsky MB, Goldowitz D. Expression of prostaglandin G/H synthase (cyclooxygenase) during murine fetal thymic development. Cell Immunol. 1991 Oct 15; 137(2):341-57.
-
Levitt MA, Dryjski M, Tluczek J, Bjornsson TD. Evaluation of a prostacyclin analog, iloprost, and a thromboxane A2 receptor antagonist, daltroban, in experimental intimal hyperplasia. Prostaglandins. 1991 Jan; 41(1):1-6.
-
Darius H, Osborne JA, Reibel DK, Lefer AM. Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium. J Mol Cell Cardiol. 1987 Mar; 19(3):243-50.